Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02358275

Ligand	Ligand name	Chain	PDB	Tanimoto
TES	TESTOSTERONE	A	1JTV	0.72
TES	TESTOSTERONE	A	2Q7L	0.72
TES	TESTOSTERONE	A	2Q7I	0.72
TES	TESTOSTERONE	A,B	1J96	0.72
TES	TESTOSTERONE	A	2Q7K	0.72
TES	TESTOSTERONE	A,B	1Q13	0.72
TES	TESTOSTERONE	H	1I9J	0.72
TES	TESTOSTERONE	A,B	1AFS	0.72
TES	TESTOSTERONE	H	1VPO	0.72
TES	TESTOSTERONE	A	2Q7J	0.72
TES	TESTOSTERONE	A,B	3BUR	0.72
TES	TESTOSTERONE	A	2AM9	0.72
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.71
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.79
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.7
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.7
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.73
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.72
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.76
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.72
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.78
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.72
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.7
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.7
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.71
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.71
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.71
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.71
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.72
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.72
HYF	4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE	A	1M13	0.78
VTQ	RRR-ALPHA-TOCOPHERYLQUINONE	A,C,E	1OLM	0.77
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDS	0.73
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDN	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.71
C0R	CORTICOSTERONE	A	2A3I	0.7
C0R	CORTICOSTERONE	A,B	1Y5R	0.7
ASY	(12E)-10-oxooctadec-12-enoic acid	A,B	3CEE	0.71
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.71
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.71
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.74
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.71
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.71